Approval on CBD sought

By Michelle Perrett

- Last updated on GMT

Mile High labs is seeking approval for its CBD isolate ingredient
Mile High labs is seeking approval for its CBD isolate ingredient

Related tags: regulations

Hemp derived cannabinoids (CBD) producer Mile High Labs has submitted a novel food application to the European Food Safety Authority (EFSA) and the UK Food Standards Agency (FSA) for its CBD isolate ingredient and CBD isolate-based finished products.

In February, the FSA stated that all CBD products on the UK market must have a novel food application through the validation phase of the review process before 31 March 2021. Under the requirements, any CBD food products failing to gain regulatory approval would be taken off the shelves.

Its application includes information on the quality of the product, hemp biomass intake controls, stability data, manufacturing controls, labelling commitments, as well as testing requirements and specifications for CBD isolate and finished products.

Mile High Labs said it had also provided an assessment of the target population, a combined intake evaluation and toxicological data that supported the safe consumption of CBD.

Related topics: NPD

Related news

Show more

Follow us

Products

View more

Webinars